These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 8594861)

  • 1. Acute renal failure induced by intravenous immune globulin.
    Arunabh ; Arunabh S; Kumar G; Avila V
    Am Fam Physician; 1996 Feb; 53(3):862, 865. PubMed ID: 8594861
    [No Abstract]   [Full Text] [Related]  

  • 2. Intravenous gammglobulin-associated acute renal failure.
    Gupta N; Ahmed I; Nissel-Horowitz S; Patel D; Mehrotra B
    Am J Hematol; 2001 Feb; 66(2):151-2. PubMed ID: 11421298
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Renal failure and intravenous immunoglobulin.
    Phillips AO
    Clin Nephrol; 1992 Apr; 37(4):217. PubMed ID: 1582064
    [No Abstract]   [Full Text] [Related]  

  • 4. Intravenous Rh(o) [D] immune globulin [human] (WinRho SDF): suspected hemolytic/renal adverse reactions.
    Parker C
    CMAJ; 2000 Oct; 163(7):881, 885. PubMed ID: 11033724
    [No Abstract]   [Full Text] [Related]  

  • 5. Reemergence of sucrose nephropathy: acute renal failure caused by high-dose intravenous immune globulin therapy.
    Zhang R; Szerlip HM
    South Med J; 2000 Sep; 93(9):901-4. PubMed ID: 11005352
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Renal toxicity of intravenous immunoglobulin.
    Kobosko J; Nicol P
    Clin Nephrol; 1992 Apr; 37(4):216-7. PubMed ID: 1582063
    [No Abstract]   [Full Text] [Related]  

  • 7. Acute renal failure complicating high-dose intravenous immunoglobulin therapy for acquired haemophilia.
    McColl MD; Omran A; Walker ID; Lowe GD
    Haemophilia; 1999 Mar; 5(2):124-6. PubMed ID: 10215961
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intravenous immunoglobulin induced-nephropathy: a complication of IVIG therapy.
    Ahsan N
    J Nephrol; 1998; 11(3):157-61. PubMed ID: 9650125
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute renal failure after intravenous anti-D immune globulin in an adult with immune thrombocytopenic purpura.
    Chun NS; Savani B; Seder RH; Taplin ME
    Am J Hematol; 2003 Dec; 74(4):276-9. PubMed ID: 14635210
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immune globulin intravenous products--notice to hospitals.
    Hogan V
    CMAJ; 1999 Apr; 160(7):1051-2, 1055-6. PubMed ID: 10207352
    [No Abstract]   [Full Text] [Related]  

  • 11. [Known and potential risks related to the use of high dose intravenous immunoglobulins].
    Bussel A
    Ann Dermatol Venereol; 1997; 124(5):381-3. PubMed ID: 9739894
    [No Abstract]   [Full Text] [Related]  

  • 12. Important drug warning: Immune Globulin Intravenous (human) (IGIV) products.
    Epstein JS; Zoon KC
    Neonatal Netw; 2000 Mar; 19(2):60-2. PubMed ID: 11949001
    [No Abstract]   [Full Text] [Related]  

  • 13. Acute renal failure after administration of intravenous immunoglobulin: review of the literature and case report.
    Winward DB; Brophy MT
    Pharmacotherapy; 1995; 15(6):765-72. PubMed ID: 8602385
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute renal failure and intravenous immune globulin: occurs with sucrose-stabilized, but not with D-sorbitol-stabilized, formulation.
    Chapman SA; Gilkerson KL; Davin TD; Pritzker MR
    Ann Pharmacother; 2004 Dec; 38(12):2059-67. PubMed ID: 15536143
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Acute renal failure following treatment with intravenously administered immunoglobulins].
    van Zanten AR; Beekhuyzen M; van der Meer YG; de Gooijer A; Feith GW
    Ned Tijdschr Geneeskd; 2003 Feb; 147(7):307-10. PubMed ID: 12622009
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impairment of renal function after intravenous immunoglobulin.
    Soares SM; Sethi S
    Nephrol Dial Transplant; 2006 Mar; 21(3):816-7. PubMed ID: 16399766
    [No Abstract]   [Full Text] [Related]  

  • 17. [Acute kidney failure secondary to intravenous immunoglobulin administration. 4 cases and review of the literature].
    Decocq G; de Cagny B; Andréjak M; Desablens B
    Therapie; 1996; 51(5):516-26. PubMed ID: 9138386
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Renal insufficiency and failure associated with immune globulin intravenous therapy--United States, 1985-1998.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 1999 Jun; 48(24):518-21. PubMed ID: 10401909
    [TBL] [Abstract][Full Text] [Related]  

  • 19. alpha1-Antitrypsin deficiency is a possible first event in the two-event model of transfusion-related acute lung injury: a proposal and case report.
    Stack G; Tormey CA
    Transfusion; 2008 Nov; 48(11):2477-8. PubMed ID: 19054378
    [No Abstract]   [Full Text] [Related]  

  • 20. [Intravenous immunoglobulins commercialized in Spain and potential risk of acute renal failure].
    Escoms Moreno MC; Riera Molist N; Montoro Ronsano JB
    Med Clin (Barc); 1999 Sep; 113(8):318. PubMed ID: 10603586
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.